DevicePMAs@therightstef:P140029_S000 JSONTXT

Annnotations TAB JSON ListView MergeView

    PMA_MER

    {"project":"PMA_MER","denotations":[{"id":"T1","span":{"begin":0,"end":8},"obj":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C25425"},{"id":"T2","span":{"begin":78,"end":84},"obj":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C12701"},{"id":"T3","span":{"begin":93,"end":103},"obj":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C54657"},{"id":"T4","span":{"begin":107,"end":115},"obj":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C61376"},{"id":"T5","span":{"begin":119,"end":125},"obj":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C70667"},{"id":"T6","span":{"begin":126,"end":132},"obj":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C161327"},{"id":"T7","span":{"begin":200,"end":203},"obj":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C25150"},{"id":"T8","span":{"begin":277,"end":283},"obj":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C12701"},{"id":"T9","span":{"begin":292,"end":302},"obj":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C54657"},{"id":"T10","span":{"begin":306,"end":314},"obj":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C61376"},{"id":"T11","span":{"begin":318,"end":324},"obj":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C70667"},{"id":"T12","span":{"begin":326,"end":330},"obj":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C25240"},{"id":"T13","span":{"begin":331,"end":337},"obj":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C161327"},{"id":"T14","span":{"begin":405,"end":408},"obj":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C25150"}],"text":"Approval for Restylane Refyne is indicated for injection into the mid-to-deep dermis for the correction of moderate to severe facial wrinkles and folds (such as nasolabial folds) in patients over the age of 21. Restylane Defyne is indicated for injection into the mid-to-deep dermis for the correction of moderate to severe, deep facial wrinkles and folds (such as nasolabial folds) in patients over the age of 21."}

    consensus_PMA_Age_Indications

    {"project":"consensus_PMA_Age_Indications","denotations":[{"id":"T1","span":{"begin":191,"end":209},"obj":"age_range"},{"id":"T3","span":{"begin":191,"end":195},"obj":"age_end"},{"id":"T5","span":{"begin":207,"end":209},"obj":"age_start"},{"id":"T2","span":{"begin":396,"end":414},"obj":"age_range"},{"id":"T4","span":{"begin":396,"end":400},"obj":"age_end"},{"id":"T6","span":{"begin":412,"end":414},"obj":"age_start"}],"text":"Approval for Restylane Refyne is indicated for injection into the mid-to-deep dermis for the correction of moderate to severe facial wrinkles and folds (such as nasolabial folds) in patients over the age of 21. Restylane Defyne is indicated for injection into the mid-to-deep dermis for the correction of moderate to severe, deep facial wrinkles and folds (such as nasolabial folds) in patients over the age of 21."}

    age_PMA_annotations

    {"project":"age_PMA_annotations","denotations":[{"id":"T1","span":{"begin":207,"end":209},"obj":"population"},{"id":"T2","span":{"begin":412,"end":414},"obj":"population"}],"text":"Approval for Restylane Refyne is indicated for injection into the mid-to-deep dermis for the correction of moderate to severe facial wrinkles and folds (such as nasolabial folds) in patients over the age of 21. Restylane Defyne is indicated for injection into the mid-to-deep dermis for the correction of moderate to severe, deep facial wrinkles and folds (such as nasolabial folds) in patients over the age of 21."}

    PMA_age_indications

    {"project":"PMA_age_indications","denotations":[{"id":"T3","span":{"begin":191,"end":195},"obj":"age_end"},{"id":"T1","span":{"begin":191,"end":209},"obj":"age_range"},{"id":"T5","span":{"begin":207,"end":209},"obj":"age_start"},{"id":"T4","span":{"begin":396,"end":400},"obj":"age_end"},{"id":"T2","span":{"begin":396,"end":414},"obj":"age_range"},{"id":"T6","span":{"begin":412,"end":414},"obj":"age_start"}],"text":"Approval for Restylane Refyne is indicated for injection into the mid-to-deep dermis for the correction of moderate to severe facial wrinkles and folds (such as nasolabial folds) in patients over the age of 21. Restylane Defyne is indicated for injection into the mid-to-deep dermis for the correction of moderate to severe, deep facial wrinkles and folds (such as nasolabial folds) in patients over the age of 21."}

    Age_blah

    {"project":"Age_blah","denotations":[{"id":"T2","span":{"begin":412,"end":414},"obj":"age_start"},{"id":"T3","span":{"begin":396,"end":400},"obj":"age_end"},{"id":"T4","span":{"begin":191,"end":195},"obj":"age_end"},{"id":"T5","span":{"begin":207,"end":209},"obj":"age_start"},{"id":"T6","span":{"begin":396,"end":414},"obj":"age_range"},{"id":"T7","span":{"begin":191,"end":209},"obj":"age_range"}],"text":"Approval for Restylane Refyne is indicated for injection into the mid-to-deep dermis for the correction of moderate to severe facial wrinkles and folds (such as nasolabial folds) in patients over the age of 21. Restylane Defyne is indicated for injection into the mid-to-deep dermis for the correction of moderate to severe, deep facial wrinkles and folds (such as nasolabial folds) in patients over the age of 21."}

    updated_tagging_age_PMA_annotations

    {"project":"updated_tagging_age_PMA_annotations","denotations":[{"id":"T1","span":{"begin":191,"end":209},"obj":"age_range"},{"id":"T2","span":{"begin":396,"end":414},"obj":"age_range"},{"id":"T3","span":{"begin":191,"end":195},"obj":"age_end"},{"id":"T4","span":{"begin":396,"end":400},"obj":"age_end"},{"id":"T5","span":{"begin":207,"end":209},"obj":"age_start"},{"id":"T6","span":{"begin":412,"end":414},"obj":"age_start"}],"text":"Approval for Restylane Refyne is indicated for injection into the mid-to-deep dermis for the correction of moderate to severe facial wrinkles and folds (such as nasolabial folds) in patients over the age of 21. Restylane Defyne is indicated for injection into the mid-to-deep dermis for the correction of moderate to severe, deep facial wrinkles and folds (such as nasolabial folds) in patients over the age of 21."}